AIM IMMUNOTECH INC. Revenue Breakdown
No Revenue Breakdown for AIM on this site yet.
- 2025-12-31: Total revenue $88.00K.
- 2024-12-31: Total revenue $170.00K.
- 2023-12-31: Total revenue $202.00K.
- 2022-12-31: Total revenue $141.00K.
Source checked: the stored Revenue Breakdown page for AIM.
Revenue by product
Each year (12 month)
| Fiscal year end | Total revenue |
|---|---|
| 2025-12-31 | $88.00K |
| 2024-12-31 | $170.00K |
| 2023-12-31 | $202.00K |
| 2022-12-31 | $141.00K |
| 2021-12-31 | $135.00K |
| 2020-12-31 | $163.00K |
| 2019-12-31 | $140.00K |
| 2018-12-31 | $367.00K |
| 2017-12-31 | $437.00K |
| 2016-12-31 | $92.00K |
| 2015-12-31 | $133.00K |
| 2014-12-31 | $197.00K |
| 2013-12-31 | $150.00K |
| 2012-12-31 | $213.00K |
| 2011-12-31 | $161.00K |
| 2010-12-31 | $135.00K |
| 2009-12-31 | $111.00K |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $26.00K 100.00% | $26.00K |
| 2026-03-31 | Not split by product $22.00K 100.00% | $22.00K |
| 2025-12-31 | Not split by product $21.00K 100.00% | $21.00K |
| 2025-09-30 | Not split by product $26.00K 100.00% | $26.00K |
| 2025-06-30 | Not split by product $25.00K 100.00% | $25.00K |
| 2025-03-31 | Not split by product $16.00K 100.00% | $16.00K |
| 2024-12-31 | Not split by product $45.00K 100.00% | $45.00K |
| 2024-09-30 | Not split by product $35.00K 100.00% | $35.00K |
| 2024-06-30 | Not split by product $50.00K 100.00% | $50.00K |
| 2024-03-31 | Not split by product $40.00K 100.00% | $40.00K |
| 2023-12-31 | Not split by product $65.00K 100.00% | $65.00K |
| 2023-09-30 | Not split by product $46.00K 100.00% | $46.00K |
| 2023-06-30 | Not split by product $42.00K 100.00% | $42.00K |
| 2023-03-31 | Not split by product $49.00K 100.00% | $49.00K |
| 2022-12-31 | Not split by product $56.00K 100.00% | $56.00K |
| 2022-09-30 | Not split by product $21.00K 100.00% | $21.00K |
| 2022-06-30 | Not split by product $30.00K 100.00% | $30.00K |
| 2022-03-31 | Not split by product $33.00K 100.00% | $33.00K |
| 2021-12-31 | Not split by product $50.00K 100.00% | $50.00K |
| 2021-09-30 | Not split by product $33.00K 100.00% | $33.00K |
| 2021-06-30 | Not split by product $23.00K 100.00% | $23.00K |
| 2021-03-31 | Not split by product $28.00K 100.00% | $28.00K |
| 2020-12-31 | Not split by product $42.00K 100.00% | $42.00K |
| 2020-09-30 | Not split by product $36.00K 100.00% | $36.00K |
| 2020-06-30 | Not split by product $40.00K 100.00% | $40.00K |
| 2020-03-31 | Not split by product $45.00K 100.00% | $45.00K |
| 2019-12-31 | Not split by product $50.00K 100.00% | $50.00K |
| 2019-09-30 | Not split by product $61.00K 100.00% | $61.00K |
| 2019-06-30 | Not split by product $29.00K 100.00% | $29.00K |
| 2018-12-31 | Not split by product $240.00K 100.00% | $240.00K |
| 2018-09-30 | Not split by product $38.00K 100.00% | $38.00K |
| 2018-06-30 | Not split by product $33.00K 100.00% | $33.00K |
| 2018-03-31 | Not split by product $56.00K 100.00% | $56.00K |
| 2017-12-31 | Not split by product $50.00K 100.00% | $50.00K |
| 2017-09-30 | Not split by product $90.00K 100.00% | $90.00K |
| 2017-06-30 | Not split by product $213.00K 100.00% | $213.00K |
| 2017-03-31 | Not split by product $84.00K 100.00% | $84.00K |
| 2016-12-31 | Not split by product $16.00K 100.00% | $16.00K |
| 2016-09-30 | Not split by product $22.00K 100.00% | $22.00K |
| 2016-06-30 | Not split by product $15.00K 100.00% | $15.00K |
| 2016-03-31 | Not split by product $39.00K 100.00% | $39.00K |
| 2015-12-31 | Not split by product $27.00K 100.00% | $27.00K |
| 2015-09-30 | Not split by product $23.00K 100.00% | $23.00K |
| 2015-06-30 | Not split by product $47.00K 100.00% | $47.00K |
| 2015-03-31 | Not split by product $36.00K 100.00% | $36.00K |
| 2014-12-31 | Not split by product $40.00K 100.00% | $40.00K |
| 2014-09-30 | Not split by product $45.00K 100.00% | $45.00K |
| 2014-06-30 | Not split by product $36.00K 100.00% | $36.00K |
| 2014-03-31 | Not split by product $76.00K 100.00% | $76.00K |
| 2013-12-31 | Not split by product $36.00K 100.00% | $36.00K |
| 2013-09-30 | Not split by product $36.00K 100.00% | $36.00K |
| 2013-06-30 | Not split by product $36.00K 100.00% | $36.00K |
| 2013-03-31 | Not split by product $42.00K 100.00% | $42.00K |
| 2012-12-31 | Not split by product $53.00K 100.00% | $53.00K |
| 2012-09-30 | Not split by product $39.00K 100.00% | $39.00K |
| 2012-06-30 | Not split by product $49.00K 100.00% | $49.00K |
| 2012-03-31 | Not split by product $72.00K 100.00% | $72.00K |
| 2011-12-31 | Not split by product $38.00K 100.00% | $38.00K |
| 2011-09-30 | Not split by product $45.00K 100.00% | $45.00K |
| 2011-06-30 | Not split by product $36.00K 100.00% | $36.00K |
| 2011-03-31 | Not split by product $42.00K 100.00% | $42.00K |
| 2010-12-31 | Not split by product $27.00K 100.00% | $27.00K |
| 2010-09-30 | Not split by product $35.00K 100.00% | $35.00K |
| 2010-06-30 | Not split by product $41.00K 100.00% | $41.00K |
| 2010-03-31 | Not split by product $32.00K 100.00% | $32.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |